BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 34694467)

  • 1. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients.
    Veleri S
    Exp Brain Res; 2022 Jan; 240(1):9-25. PubMed ID: 34694467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Neurology: An Emerging Association.
    Gupta A; Yadav P; Kumar D
    Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
    Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M
    Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.
    Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL
    Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuro-COVID-19: an insidious virus in action.
    Bratosiewicz-Wąsik J
    Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Perspective of COVID-19 on Neurology: A Mechanistic Insight.
    Kumar R; Harilal S; M S; Pappachan LK; P R R; Mathew B
    Comb Chem High Throughput Screen; 2022; 25(5):763-767. PubMed ID: 34353250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central Nervous System Manifestations Associated with COVID-19.
    Divani AA; Andalib S; Biller J; Di Napoli M; Moghimi N; Rubinos CA; Nobleza CO; Sylaja PN; Toledano M; Lattanzi S; McCullough LD; Cruz-Flores S; Torbey M; Azarpazhooh MR
    Curr Neurol Neurosci Rep; 2020 Oct; 20(12):60. PubMed ID: 33128130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    Pouga L
    J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.
    Azhar A; Wali MA; Rashid Q; Khan WH; Al-Hosaini K; Owais M; Kamal MA
    CNS Neurol Disord Drug Targets; 2023; 22(5):643-658. PubMed ID: 35440321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic Manifestations of COVID-19.
    Delavari F; Varzaneh FN; Rezaei N
    Adv Exp Med Biol; 2021; 1318():343-353. PubMed ID: 33973188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the Nervous System in SARS-CoV-2 Infection.
    Li H; Xue Q; Xu X
    Neurotox Res; 2020 Jun; 38(1):1-7. PubMed ID: 32399719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
    Zhang Y; Chen X; Jia L; Zhang Y
    Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
    Bostancıklıoğlu M
    Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.